Reduced AMR proportions were noted for multiple pathogens from 2007 to 2019, but some previously declining trends have reversed course since the COVID-19 pandemic.
A new study led by the University of Melbourne reveals that the antibiotic rifaximin contributes to the rise of vancomycin-resistant enterococcus faecium (VRE) and threatens its treatment with ...